164 related articles for article (PubMed ID: 37429637)
1. Distribution of atrial cardiomyopathy markers and association with atrial fibrillation detected after ischaemic stroke in the SAFAS study.
Didier R; Garnier L; Duloquin G; Meloux A; Sagnard A; Graber M; Dogon G; Benali K; Pommier T; Laurent G; Vergely C; Bejot Y; Guenancia C
Stroke Vasc Neurol; 2024 Apr; 9(2):165-173. PubMed ID: 37429637
[TBL] [Abstract][Full Text] [Related]
2. Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).
Kamel H; Bartz TM; Elkind MSV; Okin PM; Thacker EL; Patton KK; Stein PK; deFilippi CR; Gottesman RF; Heckbert SR; Kronmal RA; Soliman EZ; Longstreth WT
Stroke; 2018 Apr; 49(4):980-986. PubMed ID: 29535268
[TBL] [Abstract][Full Text] [Related]
3. Associations Between Atrial Cardiopathy and Cerebral Amyloid: The ARIC-PET Study.
Johansen MC; Mosley TH; Knopman DS; Wong DF; Ndumele C; Shah AM; Solomon SD; Gottesman RF
J Am Heart Assoc; 2020 Dec; 9(24):e018399. PubMed ID: 33289449
[TBL] [Abstract][Full Text] [Related]
4. Multimodal Approach for the Prediction of Atrial Fibrillation Detected After Stroke: SAFAS Study.
Garnier L; Duloquin G; Meloux A; Benali K; Sagnard A; Graber M; Dogon G; Didier R; Pommier T; Vergely C; Béjot Y; Guenancia C
Front Cardiovasc Med; 2022; 9():949213. PubMed ID: 35911547
[TBL] [Abstract][Full Text] [Related]
5. Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical Trial.
Kamel H; Longstreth WT; Tirschwell DL; Kronmal RA; Marshall RS; Broderick JP; Aragón García R; Plummer P; Sabagha N; Pauls Q; Cassarly C; Dillon CR; Di Tullio MR; Hod EA; Soliman EZ; Gladstone DJ; Healey JS; Sharma M; Chaturvedi S; Janis LS; Krishnaiah B; Nahab F; Kasner SE; Stanton RJ; Kleindorfer DO; Starr M; Winder TR; Clark WM; Miller BR; Elkind MSV;
JAMA; 2024 Feb; 331(7):573-581. PubMed ID: 38324415
[TBL] [Abstract][Full Text] [Related]
6. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.
Kamel H; Longstreth WT; Tirschwell DL; Kronmal RA; Broderick JP; Palesch YY; Meinzer C; Dillon C; Ewing I; Spilker JA; Di Tullio MR; Hod EA; Soliman EZ; Chaturvedi S; Moy CS; Janis S; Elkind MS
Int J Stroke; 2019 Feb; 14(2):207-214. PubMed ID: 30196789
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma levels of N-terminal pro-B-type natriuretic peptide as biomarker for the diagnosis of cardioembolic ischaemic stroke.
García-Carmona JA; Conesa-García E; Vidal-Mena D; González-Morales M; Ramos-Arenas V; Sánchez-Vizcaíno-Buendía C; Soria-Torrecillas JJ; Pérez-Vicente JA; García-de-Guadiana-Romualdo L
Neurologia (Engl Ed); 2024; 39(6):496-504. PubMed ID: 38901926
[TBL] [Abstract][Full Text] [Related]
8. Patterns of atrial fibrillation, relevant cardiac structural and functional changes predict functional and cognitive outcomes in patients with ischemic stroke and atrial fibrillation.
Guo J; Wang D; Jia J; Zhang J; Liu Y; Lu J; Tian Y; Zhao X
Int J Cardiol; 2024 Jul; 407():131966. PubMed ID: 38490273
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of markers of atrial cardiomyopathy in embolic stroke of undetermined source: A systematic review.
Stalikas N; Doundoulakis I; Karagiannidis E; Kartas A; Gavriilaki M; Sofidis G; Panteris E; Papazoglou AS; Haidich AB; Sianos G; Giannakoulas G
Eur J Intern Med; 2022 May; 99():38-44. PubMed ID: 35065879
[TBL] [Abstract][Full Text] [Related]
10. Embolic stroke of undetermined source: Focusing on atrial cardiopathy and patent foramen ovale.
Zhang M; Xiao Q; Wang K; Yin R; Liu G; Zhao H; Li P; Zhu X; Pan X
Int J Cardiol; 2024 May; 402():131810. PubMed ID: 38272131
[TBL] [Abstract][Full Text] [Related]
11. Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP - A narrative review.
Kerr B; Brandon L
Int J Cardiol Heart Vasc; 2022 Dec; 43():101132. PubMed ID: 36246770
[TBL] [Abstract][Full Text] [Related]
12. Atrial Cardiopathy and Cryptogenic Stroke.
Kato Y; Takahashi S
Front Neurol; 2022; 13():839398. PubMed ID: 35273560
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke.
Palà E; Pagola J; Juega J; Francisco-Pascual J; Bustamante A; Penalba A; Comas I; Rodriguez M; De Lera Alfonso M; Arenillas JF; de Torres R; Pérez-Sánchez S; Cabezas JA; Moniche F; González-Alujas T; Molina CA; Montaner J
Eur J Neurol; 2021 Feb; 28(2):540-547. PubMed ID: 33043545
[TBL] [Abstract][Full Text] [Related]
14. Atrial cardiopathy predicts detection of atrial fibrillation in embolic stroke of undetermined source: real-life data.
Silva AR; Pires C; Meira-Carvalho F; Santos M; Antunes NP; Alves JN; Ferreira C; Pinho J
Neurol Sci; 2022 Apr; 43(4):2383-2386. PubMed ID: 34708261
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
16. Atrial cardiopathy in embolic stroke of undetermined source.
Chen J; Gao F; Liu W
Brain Behav; 2021 Jun; 11(6):e02160. PubMed ID: 33942558
[TBL] [Abstract][Full Text] [Related]
17. Atrial cardiopathy and non-stenotic intracranial complicated atherosclerotic plaque in patients with embolic stroke of undetermined source.
Tao L; Dai YJ; Shang ZY; Li XQ; Wang XH; Ntaios G; Chen HS
J Neurol Neurosurg Psychiatry; 2022 Apr; 93(4):351-359. PubMed ID: 34872980
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation diagnosed after stroke and dementia risk: cohort study of first-ever ischaemic stroke patients aged 65 or older.
Krawczyk M; Fridman S; Cheng Y; Fang J; Saposnik G; Sposato LA
Europace; 2019 Dec; 21(12):1793-1801. PubMed ID: 31531673
[TBL] [Abstract][Full Text] [Related]
19. Secondary Stroke Prevention Following Embolic Stroke of Unknown Source in the Absence of Documented Atrial Fibrillation: A Clinical Review.
Kotadia ID; Sim I; Mukherjee R; O'Hare D; Chiribiri A; Birns J; Bhalla A; O'Neill M; Williams SE
J Am Heart Assoc; 2021 Jul; 10(13):e021045. PubMed ID: 34212774
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Bahit MC; Sacco RL; Easton JD; Meyerhoff J; Cronin L; Kleine E; Grauer C; Brueckmann M; Diener HC; Lopes RD; Brainin M; Lyrer P; Wachter R; Segura T; Granger CB;
Circulation; 2021 Nov; 144(22):1738-1746. PubMed ID: 34649459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
